FibroGen
FGEN
$0.43
Share price
4.24%
Change (1 day)
-81.32%
Change (1 year)
Categories
Revenue for FibroGen (FGEN)
Revenue in 2024 (TTM): A$30.26 Million
According to FibroGen's latest financial reports the company's current revenue (TTM 
) is A$47.94 Million. a decrease over the revenue in the year 2023 that were of A$0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for FibroGen from 2014 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | A$47.62 M | -78.04% |
| 2023 | A$0.21 B | 4.86% |
| 2022 | A$0.20 B | -36.28% |
| 2021 | A$0.32 B | 41.55% |
| 2020 | A$0.22 B | -37.43% |
| 2019 | A$0.36 B | 21.23% |
| 2018 | A$0.30 B | 65.3% |
| 2017 | A$0.18 B | -26.59% |
| 2016 | A$0.24 B | 0.36% |
| 2015 | A$0.24 B | 47.63% |
| 2014 | A$0.16 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | A$7.07 B | 14,660.30% | 🇺🇸 USA |
 | A$0.18 B | 280.70% | 🇺🇸 USA |
 | A$18.93 M | -60.51% | 🇺🇸 USA |